mitoxantrone has been researched along with Cat Diseases in 8 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Cat Diseases: Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To establish 2 vaccine-associated feline sarcoma (VAFS) cell lines and to determine their in vitro sensitivity to the chemotherapeutic agents doxorubicin and mitoxantrone." | 7.71 | Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. ( Banerji, N; Kanjilal, S; Kapur, V; Klausner, JS; Williams, LE, 2001) |
| "To establish 2 vaccine-associated feline sarcoma (VAFS) cell lines and to determine their in vitro sensitivity to the chemotherapeutic agents doxorubicin and mitoxantrone." | 3.71 | Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. ( Banerji, N; Kanjilal, S; Kapur, V; Klausner, JS; Williams, LE, 2001) |
| "The present case describes the treatment of a mucoepidermoid carcinoma in a 13-year-old female sterilized European domestic cat, using lung lobectomy and -accompanying mitoxantrone chemotherapy." | 1.62 | [Long-term follow-up of a multimodally managed pulmonary mucoepidermoid carcinoma in a cat]. ( Béguin, J; Lamolet, R; Manassero, M; Reyes-Gomez, E, 2021) |
| " Although the primary purpose of this study was to determine a clinically useful dosage and to characterize the toxicoses associated with mitoxantrone administration, each cat was monitored for response to treatment." | 1.29 | Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. ( Atwater, SW; Ciekot, PE; Elmslie, RE; Klein, MK; Moore, AS; Obradovich, JE; Ogilvie, GK; Salmon, MD; Straw, RC; Vail, DM, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lamolet, R | 1 |
| Manassero, M | 1 |
| Reyes-Gomez, E | 1 |
| Béguin, J | 1 |
| Cunha, SC | 1 |
| Corgozinho, KB | 1 |
| Souza, HJ | 1 |
| Silva, KV | 1 |
| Ferreira, AM | 1 |
| Ramirez, CJ | 1 |
| Minch, JD | 1 |
| Gay, JM | 1 |
| Lahmers, SM | 1 |
| Guerra, DJ | 1 |
| Haldorson, GJ | 1 |
| Schneider, T | 1 |
| Mealey, KL | 1 |
| Spugnini, EP | 1 |
| Fanciulli, M | 1 |
| Citro, G | 1 |
| Baldi, A | 1 |
| Clements, DN | 1 |
| Hogan, AM | 1 |
| Cave, TA | 1 |
| Ogilvie, GK | 1 |
| Moore, AS | 1 |
| Obradovich, JE | 1 |
| Elmslie, RE | 1 |
| Vail, DM | 1 |
| Straw, RC | 1 |
| Salmon, MD | 1 |
| Klein, MK | 1 |
| Atwater, SW | 1 |
| Ciekot, PE | 1 |
| Muleya, JS | 1 |
| Nakaichi, M | 1 |
| Taura, Y | 1 |
| Yamaguchi, R | 1 |
| Nakama, S | 1 |
| Williams, LE | 1 |
| Banerji, N | 1 |
| Klausner, JS | 1 |
| Kapur, V | 1 |
| Kanjilal, S | 1 |
1 review available for mitoxantrone and Cat Diseases
| Article | Year |
|---|---|
Preclinical models in electrochemotherapy: the role of veterinary patients.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma | 2012 |
7 other studies available for mitoxantrone and Cat Diseases
| Article | Year |
|---|---|
[Long-term follow-up of a multimodally managed pulmonary mucoepidermoid carcinoma in a cat].
Topics: Animals; Antineoplastic Agents; Carcinoma, Mucoepidermoid; Cat Diseases; Cats; Combined Modality The | 2021 |
Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Chemotherapy, Adjuvant; Combined Modality Therap | 2015 |
Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats.
Topics: Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Boron Compounds; Cat | 2011 |
Treatment of a well differentiated pulmonary adenocarcinoma in a cat by pneumonectomy and adjuvant mitoxantrone chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cat Diseases; Cats; Chemotherapy, Adjuvant; Diagnosi | 2004 |
Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors.
Topics: Animals; Anorexia; Carcinoma, Squamous Cell; Cat Diseases; Cats; Chemotherapy, Adjuvant; Dose-Respon | 1993 |
In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Cell Division; Cisplatin; Dose-Response Relation | 1999 |
Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Cell Culture Techniques; Doxorubicin; Female; In | 2001 |